Advertisement

Thyroid Gland, Gravidity and Puerperium

  • H. G. Bohnet
Conference paper

Abstract

This chapter aims at elucidating some special aspects of thyroidal disturbances and diseases. Hormonal and metabolic alterations during pregnancy exert complex influences on thyroidal function. The primary cause is an estrogen-induced surplus synthesis of thyroxine-binding globulin (TBG) in the liver, producing significantly higher serum levels of total T3 and T4. As a consequence, it is far more difficult to diagnose disturbances of thyroidal function during pregnancy and childbed when TBG decline occurs. Treatment is extremely difficult due to permeability of the placenta by certain medications or substances (e.g., thyreostatics, iodine) as opposed to others (thyroxine).

Keywords

Thyroid Gland Iodine Supply Additional Iodine Postpartum Thyroid Dysfunction Hypothyroid Mother 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aboul-Khair SA, Crooks J, Turnbull AC, Hytten FE (1964) The physiological changes in thyroid function during pregnancy. Clin Sci 27:195PubMedGoogle Scholar
  2. 2.
    Amino N, Tanizawa O, Miyai K (1978) Changes of serum immunoglobulins IgG, IgA, IgM, and IgE during pregnancy. Obstet Gynecol 52:415PubMedGoogle Scholar
  3. 3.
    Bauch K, Meng W, Ulricn FE, Grosse E, Kempe R, Schönemann F, Sterzel G, Seitz W, Möckel G, Weber A, Tiller R, Rockel A, Dempe A, Seige K (1986) Thyroid status during pregnancy and post partum in regions of iodine deficiency and endemic goiter. Endocrinol Exp 20:67–77PubMedGoogle Scholar
  4. 4.
    Bohnet HG, Kato K, Trapp M, Weise HC, Leidenberger FA (1986) Different hormonal patterns in human menopausal gonadotropin-treated, clomiphene-treated and untreated conception cycles. Fertil Steril 45:469PubMedGoogle Scholar
  5. 5.
    Bohnet HG, Fiedler K, Leidenberger FA (1981) Subclinical hypothyreoidism and infertility. Lancet II:1278CrossRefGoogle Scholar
  6. 6.
    Bohnet HG, Seeler M (1992) Häufigkeit von Schilddrüsenfunktionsstörungen post partum. Gynäkol Praxis 16:265–268Google Scholar
  7. 7.
    Bohnet HG, Knuth UA, Seeler MJ, Stranzinger JM (1992) Schilddrüsenkrankheiten in der Schwangerschaft und Stillperiode. In: Pfannenstiel P (ed) Schilddrüse und Zeiten hormoneller Umstellung: Pubertät, Schwangerschaft und Klimakterium. pp 54–58Google Scholar
  8. 8.
    Bohnet HG (1991) Strumaprophylaxe und-therapie. Der informierte Arzt. IMP 12(16a):1563–1566Google Scholar
  9. 9.
    Bohnet HG (1985) Prolaktin und weibliche Sterilität. Leitfaden für die Praxis. Grosse, BerlinGoogle Scholar
  10. 10.
    Bouillon R, Nalsens M, Vanassehe FA (1982) Hyperthyroxinemia: a cause for hyperemesis gravidarum. Am J Obstet Gynecol 143:922PubMedGoogle Scholar
  11. 11.
    Burrow GN (1985) The management of thyrotoxicosis in pregnancy. N Engl J Med 313:562–565PubMedCrossRefGoogle Scholar
  12. 12.
    Crooks J, Tulloch MI, Turnbull AC et al. Comparative incidence of goitre in pregnancy in Iceland and Scotland. Lancet 2:625Google Scholar
  13. 13.
    Davis LE, Lucas MJ, Hankins GDV, Roark ML, Cunningham FG (1989) Thyrotoxicosis complicating pregnancy. Am J Obstet 160:63–70Google Scholar
  14. 14.
    Ekins R (1985) Roles of serum thyroxine-binding proteins and maternal thyroid hormones in fetal development. Lancet: 1129–1132Google Scholar
  15. 15.
    Fehr P, Bohnet HG Postpartale Hypothyreosehäufigkeit in der Schweiz (manuscript in preparation)Google Scholar
  16. 16.
    Frilling A, Goretzki PE, Horster FA, Grußendorf M, Röher HD (1990) Subtotale Schilddrüsenresektion als Therapiekonzept bei thyreotoxischer Krise. Dtsch Med Wochenschr 115:735–739PubMedCrossRefGoogle Scholar
  17. 17.
    Gärtner R (1990) Struma — Pathophysiologie und Definition des Krankheitsbildes. In: Köbberling J, Pickardt CR (eds) Struma. Springer, Berlin Heidelberg New York, pp 7–13Google Scholar
  18. 18.
    Glinoer D, De Nayer P, Bourdoux P, Lemone M, Robyn C, Van Steirteghem A, Kinthaert J, Lejeune B (1990) Regulation of maternal thyroid during pregnancy. J Clin Endocrinol 71:276–287CrossRefGoogle Scholar
  19. 19.
    Goodwin TM, Montoro M, Mestman JH (1992) Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 167:648–652PubMedGoogle Scholar
  20. 20.
    Goretzki PE (1988) Wachstumsregulation der menschlichen Schilddrüse — TSH gesteuert? Thieme, StuttgartGoogle Scholar
  21. 21.
    Graves RJ (1925) Clinical Lectures. Med Surg J 7(2):516–517Google Scholar
  22. 22.
    Greenman GW, Gabrielson MO, Howard-Flanders J, Wessel MA (1962) Thyroid dysfunction in pregnancy. N Engl J Med 267:426PubMedCrossRefGoogle Scholar
  23. 23.
    Gutekunst R, Smolarek H, Wächter W, Scriba PC (1985) Strumaepidemiologie. Schilddrüsenvolumina bei deutschen und schwedischen Schulkindern. Dtsch Med Wochenschr 110:50–54PubMedCrossRefGoogle Scholar
  24. 24.
    Gutekunst R (1990) Jodmangel bei Kindern und Erwachsenen. In: Köbberling J, Pickardt CR (eds) Struma. Springer, Berlin Heidelberg New YorkGoogle Scholar
  25. 25.
    Harada A, Hersman JM, Reed AW et al. (1979) Comparison of thyroid stimulators and thyroid hormone concentrations in the sera of pregnant women. J Clin Endocrinol Metab 48:793PubMedCrossRefGoogle Scholar
  26. 26.
    Harris B, Fung H, Johns S et al. (1989) Transient post-partum thyroid dysfunction and postnatal depression. J Affect Disord 17:243–249PubMedCrossRefGoogle Scholar
  27. 27.
    Hashimoto H (1912) Zur Kenntnis der Lymphomatösen Veränderung der Schilddrüse (Struma Lymphomatosa). Arch Klin Chir 97:219–248Google Scholar
  28. 28.
    Hayslip CC, Fein HG, O’Donnell VM, Friedman DS, Klein TA, Smallridge RC (1988) The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction. Am J Obstet Gynecol 159:203–209PubMedGoogle Scholar
  29. 29.
    Hehrmann R (1980) Klinik und Therapie der Hypothyreose des Erwachsenen. Intern Welt 3:423–433Google Scholar
  30. 30.
    Hehrmann R (1990) Medikamentöse Therapie der Jodmangelstruma bei Kindern, Jugendlichen, jungen Erwachsenen und Schwangeren. Sozialpädiatrie 12:92–101Google Scholar
  31. 31.
    Heldin NE, Westermark B (1988) Epidermal growth factor but not thyrotropin stimulates the expression of c-fos and c-myc messenger ribonucleic acid in porcine thyroid follicle cells in primary culture. Endocrinology 122:1042–1046PubMedCrossRefGoogle Scholar
  32. 32.
    Hoff HG, Windeck R, Reinwein D (1982) Die Behandlung von Schilddrüsenerkrankungen während der Schwangerschaft. Therapiewoche 32:1028–1039Google Scholar
  33. 33.
    Horster FA, Wildmeister W, Beysel D (1990) Zur Diagnostik und Therapie von Schilddrüsenkrankheiten. Scripta Medica Merck 22Google Scholar
  34. 34.
    Jonckheer MH, Michotte Y, van Steirteghem AC, Deconinck F (1983) The adaptation of the human thyroid gland to a physiological regimen of iodide intake: evidence for a transitory inhibition of thyroid hormone secretion modulated by the intrathyroidal iodine stores. J Endocrinol Invest 6:267–271PubMedGoogle Scholar
  35. 35.
    Kalle E (1989) Letters to the Editors. NucCompact 20:181–183Google Scholar
  36. 36.
    Klein AH, Hobel CJ, Sack J, Fisher DA (1978) Effect of intra-amniotic fluid thyroxine injection on fetal serum and amniotic fluid iodothyronine concentrations. J Clin Endocrinol Metab 47:1034PubMedCrossRefGoogle Scholar
  37. 37.
    Klein AH, Meltzer S, Kenny FM (1972) Improved prognosis in congenital hypothyroidism treated before age three months. J Pediatr 81:912PubMedCrossRefGoogle Scholar
  38. 38.
    Kodama K, Sikorska H, Bayly R et al. (1984) Use of monoclonal antibodies to investigate a possible role of thyroglobulin in the pathogenesis of Graves ophthalmopathy. J Clin Endocrinol 59:67–73CrossRefGoogle Scholar
  39. 39.
    Kriss JP, Pleshokov V, Chien JR (1964) Isolation and identification of the long acting thyreoid stimulator and its relation to hyperthyroidism and circumscribed pretibial myxedema. J Clin Endocrinol Metab 24:1005–1028PubMedCrossRefGoogle Scholar
  40. 40.
    Krüskemper HL et al. (1985) Intern. Welt 8:47–49Google Scholar
  41. 41.
    Löbig H, Schatz H (1991) Schilddrüsenfunktion und Schilddrüsenantikörper in der Schwangerschaft und in der Postpartalperiode. Med Welt 42:45–52Google Scholar
  42. 42.
    Man EB, Heinemann M, Johnson CE et al. (1951) The precipitable iodine of serum in normal pregnancy and its relation to abortions. J Clin Invest 30:137PubMedCrossRefGoogle Scholar
  43. 43.
    Mandel SJ, Larsen PR, Seely EW, Brent GA (1990) Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med 323:91–96PubMedCrossRefGoogle Scholar
  44. 44.
    Mann K (1992) Schilddrüse und Klimakterium. In: Pfannenstiel P (ed) Schilddrüse und Zeiten hormoneller Umstellung: Pubertät, Schwangerschaft und Klimakterium. pp 70–78Google Scholar
  45. 45.
    Mertz DP, Sanwald R, Müller I (1959) Über den diagnostischen Wert der effektiven Halbwertszeit von J131 als Parameter für den Jodumsatz in der Schilddrüse. Dtsch Med Wochenschr 84:1901–1906CrossRefGoogle Scholar
  46. 46.
    Momotani N, Ito K, Hamada N, Ban Y, Nishikawa Y, Mimura T (1984) Maternal hyperthyroidism and congenital malformation in the offspring. J Clin Endocrinol 20:695–700CrossRefGoogle Scholar
  47. 47.
    Niswander KR, Gordon M, Berendes HW (1972) The women and their pregnancies. Saunders, PhiladelphiaGoogle Scholar
  48. 48.
    Pekonen F, Teramo K, Ikonen E, Österlund K (1984) Women on thyroid hormone therapy: pregnancy course, fetal outcome, and amniotic fluid thyroid hormone level. Obstet Gynecol 63:635PubMedGoogle Scholar
  49. 49.
    Pfannenstiel P, Sailer B (1991) Schilddrüsenkrankheiten: Diagnose und Therapie, 2nd edn. BMV, pp 72–79Google Scholar
  50. 50.
    Pfannenstiel P, Colbow B (1990) Schilddrüsenkrankheiten in der Schwangerschaft. Gynäkologe 23:47–52PubMedGoogle Scholar
  51. 51.
    Plummer HS (1913) Clinical and pathological relationships of simple and exophthalmic goiter. Trans Assoc Am Phys 43:159–167Google Scholar
  52. 52.
    Pop VJM et al. (1991) Postpartum thyroid dysfunction and depression in an unselected population. N Engl J Med 324/25:1815–1816CrossRefGoogle Scholar
  53. 53.
    Potter JD (1980) Hypothyroidism and reproductive failure. J Surg Gynecol Obstet 150:251Google Scholar
  54. 54.
    Raue F, Kohlwagen R, Ziegler R (1991) Morbus Basedow und Schwangerschaft. Med Welt 42:31–32Google Scholar
  55. 55.
    Reiners C (1991) Schilddrüsenfunktion und-funktionsparameter in der Schwangerschaft. Med Welt 42:18–24Google Scholar
  56. 56.
    Roitt IM (1993) Autoimmunerkrankungen — Begriffsumfang und Ätiologie. In: Leitfaden der Immunologie. Blackwell, Berlin, p 325Google Scholar
  57. 57.
    Rothenbuchner G, Schmidt K-J (1989) Thyroxin — ein „Geriatricum“? BMV, pp 38–39Google Scholar
  58. 58.
    Schmidt K-J, Rothenbuchner G, Reiser HH, Diehl K, Schuster H, Lagemann K, Herzberg U (1980) Die blande Struma. Therapiewoche 30:4201Google Scholar
  59. 59.
    Schmidt K-J, Rothenbuchner G, Reiser HH, Diehl K, Schuster H, Herzberg U (1980) Die kausale Therapie der primär-blanden Struma mit L-Thyroxin. Dtsch Med Wochenschr 105:1015PubMedCrossRefGoogle Scholar
  60. 60.
    Scriba PC, Börner W, Emrich D et al. (1985) Schilddrüsenfunktionsdiagnostik und die Diagnose von Schilddrüsenkrankheiten der Deutschen Gesellschaft für Endokrinologie, Sektion Schilddrüse. Intern Welt 8:50–57, 78–86Google Scholar
  61. 61.
    Stagnaro-Green A, Roman SH, Cobin RH, El-Harazy E, Alvarez-Marfany M, Davies TF (1990) Detection of at risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1422Google Scholar
  62. 62.
    Struve C, Ohlen S (1990) Einfluß früherer Schwangerschaften auf Struma-und Knotenhäufigkeit bei schilddrüsengesunden Frauen. Dtsch Med Wochenschr 115:1050–1053PubMedCrossRefGoogle Scholar
  63. 63.
    Stübner D, Gärtner R, Greil W, Gropper K, Brabant G, Permanetter W, Horn K, Pickardt CR (1987) Hypertrophy and hyperplasia during goiter growth and involution in rats — separate bioeffects of TSH and iodine. Acta Endocrinol (Copenh) 116:537–548Google Scholar
  64. 64.
    Volpe R, Row VV (1985) Evidence of antigen specific suppressor T lymphocytes in the pathogenesis of autoimmune thyroid disease. In: Walfish P, Wall JR, Volpe R (eds) Autoimmunity in the thyroid. Academic, Orlando, pp 79–94Google Scholar
  65. 65.
    Volpe R (1985) Autoimmune thyroid disease — a perspective. Mol Biol Med 3:25–51Google Scholar
  66. 66.
    Volpe R (1989) Autoimmune Thyreoiditis. In: Burrow GN, Oppenheimer JH, Volpe R (eds) Thyroid function and disease. Saunders, Philadelphia, pp 191–207Google Scholar
  67. 67.
    Volpe R (1989) Subacute thyreoiditis. In: Burrow GN, Oppenheimer JH, Volpe R (eds) Thyroid function and disease. Saunders, Philadelphia, pp 179–190Google Scholar
  68. 68.
    Volpe R (1987) Immunoregulation in autoimmune thyroid disease. N Engl J Med 316:44–46PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • H. G. Bohnet

There are no affiliations available

Personalised recommendations